Apimeds Pharmaceuticals US, Inc. announced key additions to its executive leadership team on July 15, 2025. Dr. Susan Kramer, DrPH, was appointed Senior Vice President of Development, bringing over 30 years of experience in biopharmaceutical research and development, including 18 years at Genentech.
Brian Peters joined the company as Head of its proprietary ai²™ division. Mr. Peters has a background in healthcare innovation and strategic communications, previously serving as Chief Strategy & Insights Officer at Heller Agency and VP of Sales & Marketing at Medexus Pharma.
In their new roles, Dr. Kramer will oversee all product development activities for Apitox, while Mr. Peters will lead the strategy, positioning, and launch of the ai²™ platform. These appointments are aimed at strengthening the company's clinical development capabilities and accelerating its innovation initiatives.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.